Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s):  MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.


CSE:MYCO - Post by User

Comment by agoldbloomon Nov 24, 2016 1:31pm
56 Views
Post# 25509434

RE:RE:RE:RE:RE:RE:RE:RE:I love the financials they have on their web site...

RE:RE:RE:RE:RE:RE:RE:RE:I love the financials they have on their web site...Speculative value....in theory when a spinout or split happens - the price per share should drop and in total, remain the same as what you started with.....but it never happens this way.  There are advantages to being split and more specific - in NF's case, each will react more closely to industry news in it's own country.  If you look at market caps (ignoring underlying company differences) most spec plays in the MJ arena are valued between $19-36 mill.  Others on larger exhanges are $150 mill+.  With NF splitting into 2 - the speculative value should be around $19 mill each - that works out to $0.30/share for each company ($0.60 in today shares - which is a double from here)
Bullboard Posts